bpc 157 and heart disease I’m Dr. Michael Richman, double board certified cardiothoracic surgeon. Today I talk about the peptide BPC157 separating the facts from the fiction. From more information you can go to my website at BPC-157 – Research Peptide |

Bacteriostatic Water is compatible with the vast majority of research peptides and proteins, including GLP-1 analogues, growth hormone peptides, GHRH analogues, repair peptides, and copper peptides making it the most broadly applicable and widely used reconstitution solvent in peptide research laboratories across the USA

Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics

Ovulation Trigger: Cocova-L induces the final maturation and release of the ovarian follicle, facilitating timed intercourse or intrauterine insemination (IUI)

An autoimmune-mediated strategy for prophylactic breast cancer vaccination

Overall, DHA plays a vital role in reducing the heart and circulatory disease risks